News GenKyoTex SA Euronext Paris

Equities

GKTX

FR0011790542

End-of-day quote Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

2021	Calliditas Therapeutics : Acquires Remaining Stake in Genkyotex	MT
2021	Genkyotex SA(ENXTPA:GKTX) dropped from CAC AllShares Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Calliditas Therapeutics : Acquires Remaining Stake in Genkyotex	21-10-07	MT
Calliditas Therapeutics : announces acquisition of remaining Genkyotex minority shares	21-10-07	AQ
Genkyotex SA(ENXTPA:GKTX) dropped from CAC AllShares Index	21-10-05	CI
Genkyotex SA(ENXTPA:GKTX) dropped from Next Biotech Index	21-10-05	CI
Global markets live: Sanofi, ASML, Apple, United Airlines, Netflix...	21-09-29
Global markets live: Airbnb, Coinbase, Walt Disney,...	21-05-14
Genkyotex : provides business update and reports cash position at March 31, 2021	21-05-13	PU
Calliditas Therapeutics : Year-End Report, 2020	21-02-19	AQ
Genkyotex Sa Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-18	CI
Calliditas Therapeutics : Year-End Report, 2020	21-02-18	AQ
Genkyotex : provides Q4 business update and reports cash position	21-01-27	PU
Genkyotex : announces update for near term clinical development plan for setanaxib	21-01-25	AQ
Genkyotex : Chief Medical Officer Steps Down Amid Start of Phase 2/3 Study in Chronic Liver Disease	21-01-22	MT
Genkyotex SA Announces Update for Near Term Clinical Development Plan for Setanaxib	21-01-22	CI
Calliditas Therapeutics AB : - Positive Phase 1 results in high-dose setanaxib trial	21-01-19	AQ
Genkyotex : Reports Positive Results from Phase One Trial of Anti-fibrosis Drug Setanaxib	21-01-18	MT
Calliditas Therapeutics : Positive Phase 1 results in high-dose setanaxib trial	21-01-18	AQ
Genkyotex Announces Positive Phase 1 Results Demonstrating Favorable Safety and Pharmacokinetic Profile of High-Dose Setanaxib	21-01-18	CI
Calliditas Therapeutics : announces final outcome of simplified mandatory offer to the shareholders of Genkyotex	20-12-16	AQ
Calliditas Therapeutics AB (OM:CALTX) completed the acquisition of 37.3% stake in Genkyotex SA.	20-12-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GenKyoTex SA Euronext Paris

Equities

GKTX

FR0011790542

Summary

Filters